BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 27111234)

  • 21. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
    Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.
    Rai PK; Chodisetti SB; Maurya SK; Nadeem S; Zeng W; Janmeja AK; Jackson DC; Agrewala JN
    J Transl Med; 2018 Oct; 16(1):279. PubMed ID: 30305097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell mediated responses to the mycobacterium tuberculosis specific ESAT-6 antigen in Egyptian tuberculosis patients.
    Abd El-Maged MS; Shoman SA; Al-Sherbieny MM; Barakat AB
    Egypt J Immunol; 2006; 13(1):131-40. PubMed ID: 17974157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
    Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
    J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.
    Commandeur S; van den Eeden SJ; Dijkman K; Clark SO; van Meijgaarden KE; Wilson L; Franken KL; Williams A; Christensen D; Ottenhoff TH; Geluk A
    Vaccine; 2014 Jun; 32(29):3580-8. PubMed ID: 24837764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccines.
    Grover A; Troudt J; Foster C; Basaraba R; Izzo A
    Immunology; 2014 May; 142(1):111-23. PubMed ID: 24350616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A; Hur YG; Gu S; Cho SN
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner.
    Chatterjee S; Dwivedi VP; Singh Y; Siddiqui I; Sharma P; Van Kaer L; Chattopadhyay D; Das G
    PLoS Pathog; 2011 Nov; 7(11):e1002378. PubMed ID: 22102818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
    Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
    Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil.
    de Araújo-Filho JA; Vasconcelos AC; Martins de Sousa E; Kipnis A; Ribeiro E; Junqueira-Kipnis AP
    Tuberculosis (Edinb); 2008 Sep; 88(5):474-81. PubMed ID: 18676203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gamma interferon responses of CD4 and CD8 T-cell subsets are quantitatively different and independent of each other during pulmonary Mycobacterium bovis BCG infection.
    Ngai P; McCormick S; Small C; Zhang X; Zganiacz A; Aoki N; Xing Z
    Infect Immun; 2007 May; 75(5):2244-52. PubMed ID: 17307945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice.
    Roche CM; Smith A; Lindsey DR; Meher A; Schluns K; Arora A; Armitige LY; Jagannath C
    Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1():S96-104. PubMed ID: 22082615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Subset of Mycobacteria-Specific CD4
    Yuan J; Tenant J; Pacatte T; Eickhoff C; Blazevic A; Hoft DF; Chatterjee S
    J Immunol; 2019 Aug; 203(4):972-980. PubMed ID: 31253726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of 4-1BB receptor in the control played by CD8(+) T cells on IFN-gamma production by Mycobacterium tuberculosis antigen-specific CD4(+) T Cells.
    Palma C; Vendetti S; Cassone A
    PLoS One; 2010 Jun; 5(6):e11019. PubMed ID: 20544034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection.
    Millington KA; Fortune SM; Low J; Garces A; Hingley-Wilson SM; Wickremasinghe M; Kon OM; Lalvani A
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5730-5. PubMed ID: 21427227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
    Wang QM; Kang L; Wang XH
    Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.